Studies have shown that HOXD-AS1 expression was dysregulated in certain tumours, including cervical, ovarian, glioma, liver, bladder, and non-small cell lung cancer (NSCLC) [9–15]. The gene discussed is HAGLR; the disease is neoplasm.